Published in J Infect Dis on August 01, 1988
Cholera. Clin Microbiol Rev (1995) 12.33
Structure and function of cholera toxin and the related Escherichia coli heat-labile enterotoxin. Microbiol Rev (1992) 5.15
Enterotoxigenic Escherichia coli in developing countries: epidemiology, microbiology, clinical features, treatment, and prevention. Clin Microbiol Rev (2005) 5.02
Dissociation of Escherichia coli heat-labile enterotoxin adjuvanticity from ADP-ribosyltransferase activity. Infect Immun (1995) 3.22
Occurrence, distribution, and associations of O and H serogroups, colonization factor antigens, and toxins of enterotoxigenic Escherichia coli. Clin Microbiol Rev (1997) 3.04
Prevalence of toxin types and colonization factors in enterotoxigenic Escherichia coli isolated during a 2-year period from diarrheal patients in Bangladesh. J Clin Microbiol (2000) 2.69
Disease burden due to enterotoxigenic Escherichia coli in the first 2 years of life in an urban community in Bangladesh. Infect Immun (2007) 2.07
Recombinant system for overexpression of cholera toxin B subunit in Vibrio cholerae as a basis for vaccine development. Proc Natl Acad Sci U S A (1989) 1.74
Efficacy of a low-cost, inactivated whole-cell oral cholera vaccine: results from 3 years of follow-up of a randomized, controlled trial. PLoS Negl Trop Dis (2011) 1.73
A genetically detoxified derivative of heat-labile Escherichia coli enterotoxin induces neutralizing antibodies against the A subunit. J Exp Med (1994) 1.68
Characterization of enterotoxigenic Escherichia coli isolated from U.S. troops deployed to the Middle East. J Clin Microbiol (1993) 1.57
Monoclonal antibodies against the different subcomponents of colonization factor antigen II of enterotoxigenic Escherichia coli. J Clin Microbiol (1990) 1.47
Cohort study of Guinean children: incidence, pathogenicity, conferred protection, and attributable risk for enteropathogens during the first 2 years of life. J Clin Microbiol (2003) 1.44
Phenotypic diversity of enterotoxigenic Escherichia coli strains from a community-based study of pediatric diarrhea in periurban Egypt. J Clin Microbiol (1999) 1.35
Safety and immunogenicity of a prototype enterotoxigenic Escherichia coli vaccine administered transcutaneously. Infect Immun (2002) 1.34
Antibody-secreting cells in human peripheral blood after oral immunization with an inactivated enterotoxigenic Escherichia coli vaccine. Infect Immun (1992) 1.33
Transcutaneous immunization with bacterial ADP-ribosylating exotoxins as antigens and adjuvants. Infect Immun (1999) 1.32
Part III. Analysis of data gaps pertaining to enterotoxigenic Escherichia coli infections in low and medium human development index countries, 1984-2005. Epidemiol Infect (2007) 1.30
Enterotoxigenic Escherichia coli with STh and STp genotypes is associated with diarrhea both in children in areas of endemicity and in travelers. J Clin Microbiol (2006) 1.28
Transcutaneous immunization using colonization factor and heat-labile enterotoxin induces correlates of protective immunity for enterotoxigenic Escherichia coli. Infect Immun (2002) 1.20
Construction of nontoxic derivatives of cholera toxin and characterization of the immunological response against the A subunit. Infect Immun (1995) 1.20
Surveys of human enterotoxigenic Escherichia coli from three different geographical areas for possible colonization factors. Epidemiol Infect (1991) 1.20
Rotavirus-associated diarrhea in rural Bangladesh: two-year study of incidence and serotype distribution. J Clin Microbiol (1991) 1.18
Mucosal immunization with Vibrio cholerae outer membrane vesicles provides maternal protection mediated by antilipopolysaccharide antibodies that inhibit bacterial motility. Infect Immun (2010) 1.12
Secretory IgA-mediated protection against V. cholerae and heat-labile enterotoxin-producing enterotoxigenic Escherichia coli by rice-based vaccine. Proc Natl Acad Sci U S A (2010) 1.11
Immune response, ciprofloxacin activity, and gender differences after human experimental challenge by two strains of enterotoxigenic Escherichia coli. Infect Immun (2006) 1.11
A new putative fimbrial colonization factor, CS19, of human enterotoxigenic Escherichia coli. Infect Immun (1997) 1.08
Cholera in Haiti: reproductive numbers and vaccination coverage estimates. Sci Rep (2013) 1.08
New-generation vaccines against cholera. Nat Rev Gastroenterol Hepatol (2011) 1.08
Ancestral lineages of human enterotoxigenic Escherichia coli. J Clin Microbiol (2010) 1.02
Induction of systemic antifimbria and antitoxin antibody responses in Egyptian children and adults by an oral, killed enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine. Infect Immun (2001) 1.02
Intestinal immune responses in patients infected with enterotoxigenic Escherichia coli and in vaccinees. Infect Immun (1999) 1.01
Safety and immunogenicity of an enterotoxigenic Escherichia coli vaccine patch containing heat-labile toxin: use of skin pretreatment to disrupt the stratum corneum. Infect Immun (2007) 1.01
Attenuated Shigella flexneri 2a Delta guaBA strain CVD 1204 expressing enterotoxigenic Escherichia coli (ETEC) CS2 and CS3 fimbriae as a live mucosal vaccine against Shigella and ETEC infection. Infect Immun (2001) 1.01
Attenuated Shigella flexneri 2a vaccine strain CVD 1204 expressing colonization factor antigen I and mutant heat-labile enterotoxin of enterotoxigenic Escherichia coli. Infect Immun (2000) 0.98
Heat-stable enterotoxin of enterotoxigenic Escherichia coli as a vaccine target. Infect Immun (2010) 0.98
A combination vaccine consisting of three live attenuated enterotoxigenic Escherichia coli strains expressing a range of colonization factors and heat-labile toxin subunit B is well tolerated and immunogenic in a placebo-controlled double-blind phase I trial in healthy adults. Clin Vaccine Immunol (2011) 0.97
Spatial and environmental connectivity analysis in a cholera vaccine trial. Soc Sci Med (2009) 0.97
Toxin-mediated effects on the innate mucosal defenses: implications for enteric vaccines. Infect Immun (2009) 0.95
Genotypic and phenotypic identification of coli surface antigen 6-positive enterotoxigenic Escherichia coli. J Clin Microbiol (1994) 0.95
Synthesis of hybrid molecules between heat-labile enterotoxin and cholera toxin B subunits: potential for use in a broad-spectrum vaccine. Infect Immun (1996) 0.95
Clonal relatedness of enterotoxigenic Escherichia coli strains isolated from a cohort of young children in Guinea-Bissau. J Clin Microbiol (2004) 0.93
Rapid and scalable plant-based production of a cholera toxin B subunit variant to aid in mass vaccination against cholera outbreaks. PLoS Negl Trop Dis (2013) 0.92
Construction and characterization of bivalent Shigella flexneri 2a vaccine strains SC608(pCFAI) and SC608(pCFAI/LTB) that express antigens from enterotoxigenic Escherichia coli. Infect Immun (2005) 0.92
Dose-dependent circulating immunoglobulin A antibody-secreting cell and serum antibody responses in Swedish volunteers to an oral inactivated enterotoxigenic Escherichia coli vaccine. Clin Diagn Lab Immunol (2001) 0.92
Native and mutant forms of cholera toxin and heat-labile enterotoxin effectively enhance protective efficacy of live attenuated and heat-killed Shigella vaccines. Infect Immun (1999) 0.92
Detection of colonization factor antigen I-positive enterotoxigenic Escherichia coli with a cloned polynucleotide probe. J Clin Microbiol (1990) 0.91
Directed evaluation of enterotoxigenic Escherichia coli autotransporter proteins as putative vaccine candidates. PLoS Negl Trop Dis (2011) 0.90
Construction and phase I clinical evaluation of the safety and immunogenicity of a candidate enterotoxigenic Escherichia coli vaccine strain expressing colonization factor antigen CFA/I. Infect Immun (2006) 0.90
Genetic relationship of putative colonization factor O166 to colonization factor antigen I and coli surface antigen 4 of enterotoxigenic Escherichia coli. Infect Immun (1992) 0.89
A combined vaccine approach against Vibrio cholerae and ETEC based on outer membrane vesicles. Front Microbiol (2015) 0.89
Immune responses in ileostomy fluid and serum after oral cholera vaccination of patients colectomized because of ulcerative colitis. Infect Immun (1998) 0.88
New Developments in Traveler's Diarrhea. Gastroenterol Hepatol (N Y) (2011) 0.86
Effectiveness and economic analysis of the whole cell/recombinant B subunit (WC/rbs) inactivated oral cholera vaccine in the prevention of traveller's diarrhoea. BMC Infect Dis (2009) 0.84
Vaccines for viral and bacterial pathogens causing acute gastroenteritis: Part II: Vaccines for Shigella, Salmonella, enterotoxigenic E. coli (ETEC) enterohemorragic E. coli (EHEC) and Campylobacter jejuni. Hum Vaccin Immunother (2015) 0.84
Methods to assess the impact of mass oral cholera vaccination campaigns under real field conditions. PLoS One (2014) 0.82
Vaccines against traveler's diarrhoea and rotavirus disease - a review. Wien Klin Wochenschr (2006) 0.81
Maternal Vaccination with a Fimbrial Tip Adhesin and Passive Protection of Neonatal Mice against Lethal Human Enterotoxigenic Escherichia coli Challenge. Infect Immun (2015) 0.80
Use of nonradioactive DNA hybridization for identification of enterotoxigenic Escherichia coli harboring genes for colonization factor antigen I, coli surface antigen 4, or putative colonization factor O166. J Clin Microbiol (1992) 0.80
Limited clonal relatedness between gut IgA plasma cells and memory B cells after oral immunization. Nat Commun (2016) 0.80
Critical analysis of compositions and protective efficacies of oral killed cholera vaccines. Clin Vaccine Immunol (2014) 0.79
Effectiveness of the WC/rBS oral cholera vaccine in the prevention of traveler's diarrhea: a prospective cohort study. Hum Vaccin Immunother (2013) 0.79
Designing vaccines to neutralize effective toxin delivery by enterotoxigenic Escherichia coli. Toxins (Basel) (2014) 0.79
Immunogenicity of nuclear-encoded LTB:ST fusion protein from Escherichia coli expressed in tobacco plants. Plant Cell Rep (2011) 0.79
[Examples for vaccines against diarrheal diseases--rotavirus and traveller's diarrhea]. Wien Med Wochenschr (2007) 0.78
Evaluation of the Safety, Tolerability, and Immunogenicity of an Oral, Inactivated Whole-Cell Shigella flexneri 2a Vaccine in Healthy Adult Subjects. Clin Vaccine Immunol (2016) 0.76
The hows and whys of constructing a native recombinant cholera vaccine. Bioengineered (2013) 0.75
Pilot study of whole-blood gamma interferon response to the Vibrio cholerae toxin B subunit and resistance to enterotoxigenic Escherichia coli-associated diarrhea. Clin Vaccine Immunol (2010) 0.75
Achievements and challenges for the use of killed oral cholera vaccines in the global stockpile era. Hum Vaccin Immunother (2016) 0.75
Safety and immunogenicity of escalating dosages of a single oral administration of peru-15 pCTB, a candidate live, attenuated vaccine against enterotoxigenic Escherichia coli and Vibrio cholerae. Clin Vaccine Immunol (2014) 0.75
Pathogen-induced secretory diarrhea and its prevention. Eur J Clin Microbiol Infect Dis (2016) 0.75
The regulation of gut mucosal IgA B-cell responses: recent developments. Mucosal Immunol (2017) 0.75
Test for enterotoxigenic Escherichia coli using Y-1 adrenal cells in miniculture. Infect Immun (1975) 13.58
Human reovirus-like agent as the major pathogen associated with "winter" gastroenteritis in hospitalized infants and young children. N Engl J Med (1976) 7.57
Reviews of evidence regarding interventions to reduce tobacco use and exposure to environmental tobacco smoke. Am J Prev Med (2001) 7.47
Travelers' diarrhea in Mexico. A prospective study of physicians and family members attending a congress. N Engl J Med (1976) 6.52
Developing an evidence-based Guide to Community Preventive Services--methods. The Task Force on Community Preventive Services. Am J Prev Med (2000) 6.43
Prostitution and risk of HIV: female prostitutes in London. BMJ (1993) 6.06
The body-mass index of twins who have been reared apart. N Engl J Med (1990) 5.11
Special Escherichia coli serotypes among enterotoxigenic strains from diarrhoea in adults and children. Med Microbiol Immunol (1976) 4.95
Endemic cholera in rural Bangladesh, 1966-1980. Am J Epidemiol (1982) 4.93
Seasonal affective disorder. A description of the syndrome and preliminary findings with light therapy. Arch Gen Psychiatry (1984) 4.72
Reproductive-tract infections in women in low-income, low-prevalence situations: assessment of syndromic management in Matlab, Bangladesh. Lancet (1999) 4.67
Changing disease patterns in patients with AIDS in a referral centre in the United Kingdom: the changing face of AIDS. BMJ (1991) 4.67
Field trial of oral cholera vaccines in Bangladesh: results from three-year follow-up. Lancet (1990) 4.62
Does rectal gonorrhoea reflect unsafe sex? Lancet (1991) 3.99
Prostitute women and public health. BMJ (1988) 3.76
Surveillance of patients attending a diarrhoeal disease hospital in Bangladesh. Br Med J (Clin Res Ed) (1982) 3.75
Attachment of Vibrio cholerae serogroup O1 to zooplankton and phytoplankton of Bangladesh waters. Appl Environ Microbiol (1990) 3.73
Priorities among recommended clinical preventive services. Am J Prev Med (2001) 3.70
Enterotoxigenic Escherichia coli isolated from food. J Infect Dis (1977) 3.52
Cholera control. Lancet (1994) 3.38
Enterotoxigenic Escherichia coli and Reovirus-like agent in rural Bangladesh. Lancet (1976) 3.38
Laboratory investigation of diarrhea in travelers to Mexico: evaluation of methods for detecting enterotoxigenic Echerichia coli. J Clin Microbiol (1976) 3.34
Microtiter ganglioside enzyme-linked immunosorbent assay for vibrio and Escherichia coli heat-labile enterotoxins and antitoxin. J Clin Microbiol (1980) 3.30
Diarrhoea associated with heat-stable enterotoxin-producing strains of Escherichia coli. Lancet (1975) 3.27
Detection of Vibrio cholerae O1 in the aquatic environment by fluorescent-monoclonal antibody and culture methods. Appl Environ Microbiol (1990) 3.21
Optic flow is used to control human walking. Nat Neurosci (2001) 3.12
Mucosal antitoxic and antibacterial immunity after cholera disease and after immunization with a combined B subunit-whole cell vaccine. J Infect Dis (1984) 3.07
Social influences on the sexual behavior of youth at risk for HIV exposure. Am J Public Health (1994) 2.95
High-molecular-weight plasmid correlates with Escherichia coli enteroinvasiveness. Infect Immun (1982) 2.95
Impact of perceived parental monitoring on adolescent risk behavior over 4 years. J Adolesc Health (2000) 2.92
A comparison of three verbal autopsy methods to ascertain levels and causes of maternal deaths in Matlab, Bangladesh. Int J Epidemiol (1998) 2.86
Prophylactic doxycycline for travelers' diarrhea. Results of a prospective double-blind study of Peace Corps volunteers in Kenya. N Engl J Med (1978) 2.86
Field trial of oral cholera vaccines in Bangladesh. Lancet (1986) 2.85
Effect on mortality of community-based maternity-care programme in rural Bangladesh. Lancet (1991) 2.82
Perceived parental monitoring and health risk behaviors among urban low-income African-American children and adolescents. J Adolesc Health (2000) 2.81
Epidemic diarrhea at Crater Lake from enterotoxigenic Escherichia coli. A large waterborne outbreak. Ann Intern Med (1977) 2.80
Candida albicans resistance in AIDS. J Infect (1991) 2.78
Seroepidemiological studies of El Tor cholera in Bangladesh: association of serum antibody levels with protection. J Infect Dis (1985) 2.78
Long-term radiation complications following conservative surgery (CS) and radiation therapy (RT) in patients with early stage breast cancer. Int J Radiat Oncol Biol Phys (1992) 2.78
Relationship of patient age to pathologic features of the tumor and prognosis for patients with stage I or II breast cancer. J Clin Oncol (1994) 2.77
Enterotoxigenic Escherichia-coli-associated diarrheal disease in Apache children. N Engl J Med (1975) 2.74
The sequencing of chemotherapy and radiation therapy after conservative surgery for early-stage breast cancer. N Engl J Med (1996) 2.74
Microtiter solid-phase radioimmunoassay for detection of Escherichia coli heat-labile enterotoxin. Infect Immun (1977) 2.72
Reduction of cholera in Bangladeshi villages by simple filtration. Proc Natl Acad Sci U S A (2003) 2.68
Failure of sanitary wells to protect against cholera and other diarrhoeas in Bangladesh. Lancet (1976) 2.64
El Tor cholera with severe disease: a new threat to Asia and beyond. Epidemiol Infect (2009) 2.60
Improved thin-layer chromatographic method for the separation of major phospholipids and glycolipids from plant lipid extracts and phosphatidyl glycerol and bis(monoacylglyceryl) phosphate from animal lipid extracts. J Chromatogr (1977) 2.55
HTLV-III: should testing ever be routine? Br Med J (Clin Res Ed) (1986) 2.51
Radiation therapy of early carcinoma of the breast without mastectomy. Cancer (1980) 2.49
Predisposition for cholera of individuals with O blood group. Possible evolutionary significance. Am J Epidemiol (1985) 2.49
Studies of cellular immunity in male homosexuals in London. Lancet (1983) 2.41
Effectiveness of the 40 adolescent AIDS-risk reduction interventions: a quantitative review. J Adolesc Health (1997) 2.37
Experimental non-O group 1 Vibrio cholerae gastroenteritis in humans. J Clin Invest (1990) 2.33
Virulence and phenotypic characterization of Yersinia enterocolitica isolated from humans in the United States. J Clin Microbiol (1983) 2.32
Plasmid-mediated resistance to nalidixic acid in Shigella dysenteriae type 1. Lancet (1987) 2.32
The complete set of predicted genes from Saccharomyces cerevisiae in a readily usable form. Genome Res (1997) 2.31
Rape and subsequent seroconversion to HIV. BMJ (1989) 2.26
The relationship between shaved margin and inked margin status in breast excision specimens. Cancer (1997) 2.22
Improved methodology for analyzing local and distant recurrence. J Clin Oncol (1990) 2.21
Methods for systematic reviews of economic evaluations for the Guide to Community Preventive Services. Task Force on Community Preventive Services. Am J Prev Med (2000) 2.20
Tissue-culture assay of antibodies to heat-liable Escherichia coli enterotoxins. N Engl J Med (1974) 2.20
Intestinal antibody responses after immunisation with cholera B subunit. Lancet (1982) 2.13
Classical Vibrio cholerae biotype displaces EL tor in Bangladesh. Lancet (1983) 2.12
Analysis of cosmetic results following primary radiation therapy for stages I and II carcinoma of the breast. Int J Radiat Oncol Biol Phys (1979) 2.10
Parental influence on adolescent sexual behavior in high-poverty settings. Arch Pediatr Adolesc Med (1999) 2.06
Methods for priority setting among clinical preventive services. Am J Prev Med (2001) 2.05
Decline in maternal mortality in Matlab, Bangladesh: a cautionary tale. Lancet (1998) 2.04
Three-year prospective study of HTLV-III/LAV infection in homosexual men. Lancet (1986) 2.04
Enterotoxigenic Escherichia coli isolated from patients at a hospital in Dacca. J Infect Dis (1977) 2.03
New virulence-associated plasmid in Yersinia enterocolitica. J Clin Microbiol (1982) 2.03
To boost or not to boost, and how to do it. Int J Radiat Oncol Biol Phys (1991) 2.02
Anaphase structure in mitotic cells typified by spindle elongation. J Ultrastruct Res (1966) 1.98
Vicilin with carboxy-terminal KDEL is retained in the endoplasmic reticulum and accumulates to high levels in the leaves of transgenic plants. Plant J (1992) 1.96
Impact of measles vaccination on childhood mortality in rural Bangladesh. Bull World Health Organ (1990) 1.95
Pathologic predictors of early local recurrence in Stage I and II breast cancer treated by primary radiation therapy. Cancer (1984) 1.95
Antimicrobial resistance of Shigella isolates in Bangladesh, 1983-1990: increasing frequency of strains multiply resistant to ampicillin, trimethoprim-sulfamethoxazole, and nalidixic acid. Clin Infect Dis (1992) 1.89
Sexually transmitted diseases in homosexual relationships. J Ir Med Assoc (1972) 1.89
Outcome at 8 years after breast-conserving surgery and radiation therapy for invasive breast cancer: influence of margin status and systemic therapy on local recurrence. J Clin Oncol (2000) 1.89
Preventing the spread of HIV infection. BMJ (1991) 1.88
Interruption of shigellosis by hand washing. Trans R Soc Trop Med Hyg (1982) 1.88
Enterotoxigenic Escherichia coli diarrhea of travelers: a prospective study of American Peace Corps volunteers. Johns Hopkins Med J (1977) 1.88
Acute toxicity of vitamin A given with vaccines in infancy. Lancet (1993) 1.87
The Matlab family planning-health services project. Stud Fam Plann (1980) 1.85
Latency versus persistence or intermittent recurrences: evidence for a latent state of murine cytomegalovirus in the lungs. J Virol (1997) 1.82
Rapid diagnosis of cholera by coagglutination test using 4-h fecal enrichment cultures. J Clin Microbiol (1987) 1.82
Irritable bowel syndrome in twins: genes and environment. Gut (2006) 1.81
Epidemiologic and clinical features of patients infected with Shigella who attended a diarrheal disease hospital in Bangladesh. J Infect Dis (1982) 1.79
Oral hydration rotavirus diarrhoea: a double blind comparison of sucrose with glucose electrolyte solution. Lancet (1978) 1.78
Sexual assault of men: a series. Genitourin Med (1990) 1.77